Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Background - Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin lymphoma. In the FLYER trial, we assessed whether four cycles of CHOP plus six applications of rituximab are non-inferior to six...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
19 December 2019
|
| In: |
The lancet
Year: 2019, Volume: 394, Issue: 10216, Pages: 2271-2281 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(19)33008-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0140-6736(19)33008-9 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0140673619330089 
|
| Author Notes: | Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens-Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz-Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice di Rocco, Ralf Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glass, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1696975034 | ||
| 003 | DE-627 | ||
| 005 | 20230427121950.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200430s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(19)33008-9 |2 doi | |
| 035 | |a (DE-627)1696975034 | ||
| 035 | |a (DE-599)KXP1696975034 | ||
| 035 | |a (OCoLC)1341317775 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pöschel, Viola |d 1971- |e VerfasserIn |0 (DE-588)1147246068 |0 (DE-627)1008587354 |0 (DE-576)45202188X |4 aut | |
| 245 | 1 | 0 | |a Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) |b a randomised, phase 3, non-inferiority trial |c Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens-Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz-Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice di Rocco, Ralf Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glass, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh |
| 264 | 1 | |c 19 December 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.04.2020 | ||
| 520 | |a Background - Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin lymphoma. In the FLYER trial, we assessed whether four cycles of CHOP plus six applications of rituximab are non-inferior to six cycles of R-CHOP in a population of patients with B-cell non-Hodgkin lymphoma with favourable prognosis. - Methods - This two-arm, open-label, international, multicentre, prospective, randomised phase 3 non-inferiority trial was done at 138 clinical sites in Denmark, Israel, Italy, Norway, and Germany. We enrolled patients aged 18-60 years, with stage I-II disease, normal serum lactate dehydrogenase concentration, ECOG performance status 0-1, and without bulky disease (maximal tumour diameter <7·5 cm). Randomisation was computer-based and done centrally in a 1:1 ratio using the Pocock minimisation algorithm after stratification for centres, stage (I vs II), and extralymphatic sites (no vs yes). Patients were assigned to receive either six cycles of R-CHOP or four cycles of R-CHOP plus two doses of rituximab. CHOP comprised cyclophosphamide (750 mg/m2), doxorubicin (50 mg/m2), and vincristine (1·4 mg/m2, with a maximum total dose of 2 mg), all administered intravenously on day 1, plus oral prednisone or prednisolone at the discretion of the investigator (100 mg) administered on days 1-5. Rituximab was given at a dose of 375 mg/m2 of body surface area. Cycles were repeated every 21 days. No radiotherapy was planned except for testicular lymphoma treatment. The primary endpoint was progression-free survival after 3 years. The primary analysis was done in the intention-to-treat population. Safety was assessed in all patients who received at least one dose of assigned treatment. A non-inferiority margin of −5·5% was chosen. The trial, which is completed, was prospectively registered at ClinicalTrials.gov, NCT00278421. - Findings - Between Dec 2, 2005, and Oct 7, 2016, 592 patients were enrolled, of whom 295 patients were randomly assigned to receive six cycles of R-CHOP and 297 were assigned to receive four cycles of R-CHOP plus two doses of rituximab. Four patients in the four-cycles group withdrew informed consent before the start of treatment, so 588 patients were included in the intention-to-treat analysis. After a median follow-up of 66 months (IQR 42-100), 3-year progression-free survival of patients who had four cycles of R-CHOP plus two doses of rituximab was 96% (95% CI 94-99), which was 3% better (lower limit of the one-sided 95% CI for the difference was 0%) than six cycles of R-CHOP, demonstrating the non-inferiority of the four-cycles regimen. 294 haematological and 1036 non-haematological adverse events were documented in the four-cycles group compared with 426 haematological and 1280 non-haematological adverse events in the six-cycles group. Two patients, both in the six-cycles group, died during study therapy. - Interpretation - In young patients with aggressive B-cell non-Hodgkin lymphoma and favourable prognosis, four cycles of R-CHOP is non-inferior to six cycles of R-CHOP, with relevant reduction of toxic effects. Thus, chemotherapy can be reduced without compromising outcomes in this population. - Funding - Deutsche Krebshilfe. | ||
| 700 | 1 | |a Held, Gerhard Wolfgang |d 1968- |e VerfasserIn |0 (DE-588)121959716 |0 (DE-627)081647948 |0 (DE-576)293018693 |4 aut | |
| 700 | 1 | |a Ziepert, Marita |d 1965- |e VerfasserIn |0 (DE-588)143050532 |0 (DE-627)641864728 |0 (DE-576)334792827 |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 700 | 1 | |a Holte, Harald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thurner, Lorenz |d 1982- |e VerfasserIn |0 (DE-588)1016795874 |0 (DE-627)705578372 |0 (DE-576)349455260 |4 aut | |
| 700 | 1 | |a Borchmann, Peter |e VerfasserIn |0 (DE-588)107278842X |0 (DE-627)82823762X |0 (DE-576)434245321 |4 aut | |
| 700 | 1 | |a Viardot, Andreas |d 1968- |e VerfasserIn |0 (DE-588)123546605 |0 (DE-627)082621357 |0 (DE-576)184707498 |4 aut | |
| 700 | 1 | |a Sökler, Martin |d 1965- |e VerfasserIn |0 (DE-588)1034292501 |0 (DE-627)745191762 |0 (DE-576)381921700 |4 aut | |
| 700 | 1 | |a Keller, Ulrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmidt, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Truemper, Lorenz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mahlberg, Rolf |d 1959- |e VerfasserIn |0 (DE-588)112117856 |0 (DE-627)476592305 |0 (DE-576)289721911 |4 aut | |
| 700 | 1 | |a Marks, Reinhard |d 1967- |e VerfasserIn |0 (DE-588)120105292 |0 (DE-627)080449581 |0 (DE-576)292044402 |4 aut | |
| 700 | 1 | |a Hoeffkes, Heinz-Gert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Metzner, Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dierlamm, Judith |e VerfasserIn |0 (DE-588)1028107048 |0 (DE-627)730358585 |0 (DE-576)375643672 |4 aut | |
| 700 | 1 | |a Frickhofen, Norbert |d 1954- |e VerfasserIn |0 (DE-588)1145666302 |0 (DE-627)1006855084 |0 (DE-576)16713535X |4 aut | |
| 700 | 1 | |a Hänel, Mathias |d 1964- |e VerfasserIn |0 (DE-588)17362295X |0 (DE-627)698532414 |0 (DE-576)134465970 |4 aut | |
| 700 | 1 | |a Neubauer, Andreas |d 1958- |e VerfasserIn |0 (DE-588)136452981 |0 (DE-627)583296807 |0 (DE-576)301028303 |4 aut | |
| 700 | 1 | |a Kneba, Michael |d 1950- |e VerfasserIn |0 (DE-588)101170644X |0 (DE-627)659309726 |0 (DE-576)343539187 |4 aut | |
| 700 | 1 | |a Merli, Francesco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tucci, Alessandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Nully Brown, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Federico, Massimo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lengfelder, Eva |d 1951- |e VerfasserIn |0 (DE-588)1031229779 |0 (DE-627)736022775 |0 (DE-576)378669230 |4 aut | |
| 700 | 1 | |a di Rocco, Alice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trappe, Ralf Ulrich |d 1971- |e VerfasserIn |0 (DE-588)123859344 |0 (DE-627)085485977 |0 (DE-576)293913285 |4 aut | |
| 700 | 1 | |a Rosenwald, Andreas |d 1967- |e VerfasserIn |0 (DE-588)1111788189 |0 (DE-627)865894868 |0 (DE-576)476255104 |4 aut | |
| 700 | 1 | |a Berdel, Christian |d 1979- |e VerfasserIn |0 (DE-588)1012547973 |0 (DE-627)704882574 |0 (DE-576)339732474 |4 aut | |
| 700 | 1 | |a Maisenhoelder, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shpilberg, Ofer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Amam, Josif |e VerfasserIn |4 aut | |
| 700 | 1 | |a Christofyllakis, Konstantinos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hartmann, Frank |d 1962- |e VerfasserIn |0 (DE-588)118107186 |0 (DE-627)694674362 |0 (DE-576)302548130 |4 aut | |
| 700 | 1 | |a Murawski, Niels Michael |d 1971- |e VerfasserIn |0 (DE-588)122720075 |0 (DE-627)706013484 |0 (DE-576)183936256 |4 aut | |
| 700 | 1 | |a Stilgenbauer, Stephan |d 1966- |e VerfasserIn |0 (DE-588)114728380 |0 (DE-627)590333151 |0 (DE-576)302364781 |4 aut | |
| 700 | 1 | |a Nickelsen, Maike |d 1968- |e VerfasserIn |0 (DE-588)120390981 |0 (DE-627)696628554 |0 (DE-576)292193645 |4 aut | |
| 700 | 1 | |a Wulf, Gerald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Glaß, Bertram |d 1960- |e VerfasserIn |0 (DE-588)121205630 |0 (DE-627)705305538 |0 (DE-576)292585462 |4 aut | |
| 700 | 1 | |a Schmitz, Norbert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Altmann, Bettina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Löffler, Markus W. |d 1978- |e VerfasserIn |0 (DE-588)13832316X |0 (DE-627)696505134 |0 (DE-576)30665346X |4 aut | |
| 700 | 1 | |a Pfreundschuh, Michael |d 1949-2018 |e VerfasserIn |0 (DE-588)108615871 |0 (DE-627)394701879 |0 (DE-576)289617227 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet |d London [u.a.] : Elsevier, 1823 |g 394(2019), 10216, Seite 2271-2281 |h Online-Ressource |w (DE-627)270128484 |w (DE-600)1476593-7 |w (DE-576)078590159 |x 1474-547X |7 nnas |a Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) a randomised, phase 3, non-inferiority trial |
| 773 | 1 | 8 | |g volume:394 |g year:2019 |g number:10216 |g pages:2271-2281 |g extent:11 |a Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) a randomised, phase 3, non-inferiority trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(19)33008-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0140673619330089 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200430 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1031229779 |a Lengfelder, Eva |m 1031229779:Lengfelder, Eva |d 60000 |d 61200 |e 60000PL1031229779 |e 61200PL1031229779 |k 0/60000/ |k 1/60000/61200/ |p 26 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1696975034 |e 3646605588 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1696975034","note":["Gesehen am 30.04.2020"],"name":{"displayForm":["Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens-Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz-Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice di Rocco, Ralf Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glass, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh"]},"relHost":[{"pubHistory":["1.1823 -"],"recId":"270128484","disp":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) a randomised, phase 3, non-inferiority trialThe lancet","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"The lancet","title_sort":"lancet"}],"titleAlt":[{"title":"The lancet <London>"},{"title":"London lancet"},{"title":"Lancet (British ed. Online)"}],"part":{"issue":"10216","extent":"11","year":"2019","text":"394(2019), 10216, Seite 2271-2281","pages":"2271-2281","volume":"394"},"origin":[{"dateIssuedKey":"1823","publisher":"Elsevier ; The Lancet Ltd.","dateIssuedDisp":"1823-","publisherPlace":"London [u.a.] ; London"}],"id":{"eki":["270128484"],"issn":["1474-547X"],"zdb":["1476593-7"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"title":[{"title_sort":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER)","title":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER)","subtitle":"a randomised, phase 3, non-inferiority trial"}],"person":[{"role":"aut","display":"Pöschel, Viola","family":"Pöschel","given":"Viola"},{"role":"aut","given":"Gerhard Wolfgang","family":"Held","display":"Held, Gerhard Wolfgang"},{"role":"aut","given":"Marita","family":"Ziepert","display":"Ziepert, Marita"},{"role":"aut","family":"Witzens-Harig","display":"Witzens-Harig, Mathias","given":"Mathias"},{"given":"Harald","display":"Holte, Harald","family":"Holte","role":"aut"},{"role":"aut","family":"Thurner","display":"Thurner, Lorenz","given":"Lorenz"},{"role":"aut","given":"Peter","display":"Borchmann, Peter","family":"Borchmann"},{"role":"aut","display":"Viardot, Andreas","family":"Viardot","given":"Andreas"},{"role":"aut","display":"Sökler, Martin","family":"Sökler","given":"Martin"},{"family":"Keller","display":"Keller, Ulrich","given":"Ulrich","role":"aut"},{"role":"aut","given":"Christian","family":"Schmidt","display":"Schmidt, Christian"},{"role":"aut","family":"Truemper","display":"Truemper, Lorenz","given":"Lorenz"},{"given":"Rolf","display":"Mahlberg, Rolf","family":"Mahlberg","role":"aut"},{"role":"aut","display":"Marks, Reinhard","family":"Marks","given":"Reinhard"},{"family":"Hoeffkes","display":"Hoeffkes, Heinz-Gert","given":"Heinz-Gert","role":"aut"},{"role":"aut","given":"Bernd","display":"Metzner, Bernd","family":"Metzner"},{"role":"aut","given":"Judith","family":"Dierlamm","display":"Dierlamm, Judith"},{"role":"aut","family":"Frickhofen","display":"Frickhofen, Norbert","given":"Norbert"},{"role":"aut","display":"Hänel, Mathias","family":"Hänel","given":"Mathias"},{"role":"aut","given":"Andreas","family":"Neubauer","display":"Neubauer, Andreas"},{"role":"aut","given":"Michael","display":"Kneba, Michael","family":"Kneba"},{"role":"aut","display":"Merli, Francesco","family":"Merli","given":"Francesco"},{"given":"Alessandra","family":"Tucci","display":"Tucci, Alessandra","role":"aut"},{"given":"Peter","display":"de Nully Brown, Peter","family":"de Nully Brown","role":"aut"},{"given":"Massimo","display":"Federico, Massimo","family":"Federico","role":"aut"},{"given":"Eva","display":"Lengfelder, Eva","family":"Lengfelder","role":"aut"},{"role":"aut","display":"di Rocco, Alice","family":"di Rocco","given":"Alice"},{"display":"Trappe, Ralf Ulrich","family":"Trappe","given":"Ralf Ulrich","role":"aut"},{"role":"aut","given":"Andreas","family":"Rosenwald","display":"Rosenwald, Andreas"},{"role":"aut","family":"Berdel","display":"Berdel, Christian","given":"Christian"},{"given":"Martin","family":"Maisenhoelder","display":"Maisenhoelder, Martin","role":"aut"},{"given":"Ofer","display":"Shpilberg, Ofer","family":"Shpilberg","role":"aut"},{"given":"Josif","family":"Amam","display":"Amam, Josif","role":"aut"},{"role":"aut","display":"Christofyllakis, Konstantinos","family":"Christofyllakis","given":"Konstantinos"},{"given":"Frank","family":"Hartmann","display":"Hartmann, Frank","role":"aut"},{"given":"Niels Michael","family":"Murawski","display":"Murawski, Niels Michael","role":"aut"},{"given":"Stephan","family":"Stilgenbauer","display":"Stilgenbauer, Stephan","role":"aut"},{"role":"aut","given":"Maike","family":"Nickelsen","display":"Nickelsen, Maike"},{"role":"aut","family":"Wulf","display":"Wulf, Gerald","given":"Gerald"},{"family":"Glaß","display":"Glaß, Bertram","given":"Bertram","role":"aut"},{"role":"aut","given":"Norbert","display":"Schmitz, Norbert","family":"Schmitz"},{"family":"Altmann","display":"Altmann, Bettina","given":"Bettina","role":"aut"},{"family":"Löffler","display":"Löffler, Markus W.","given":"Markus W.","role":"aut"},{"given":"Michael","display":"Pfreundschuh, Michael","family":"Pfreundschuh","role":"aut"}],"physDesc":[{"extent":"11 S."}],"id":{"eki":["1696975034"],"doi":["10.1016/S0140-6736(19)33008-9"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"19 December 2019"}]} | ||
| SRT | |a POESCHELVIFOURVERSUS1920 | ||